title: LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.
abstract: The L.E.A.P.S.(™) (Ligand Epitope Antigen Presentation System) technology platform has been used to develop immunoprotective and immunomodulating small peptide vaccines for infectious and autoimmune diseases. Several products are currently in various stages of development, at the pre-clinical stage (in animal challenge efficacy studies). Vaccine peptides can elicit protection of animals from lethal viral (herpes simplex virus [HSV-1] and influenza A) infection or can block the progression of autoimmune diseases (e.g. rheumatoid arthritis as in the collagen induced arthritis (CIA] or experimental autoimmune myocarditis (EAM) models). L.E.A.P.S. technology is a novel T-cell immunization technology that enables the design and synthesis of non-recombinant, proprietary peptide immunogens. Combination of a small peptide that activates the immune system with another small peptide from a disease-related protein, thus a conjugate containing both an Immune Cell Binding Ligand (ICBL) and a disease specific epitope, which allows the L.E.A.P.S. vaccines to activate precursors to differentiate and become more mature cells that can initiate and direct appropriate T cell responses. As such, readily synthesized, defined immunogens can be prepared to different diseases and are likely to elicit protection or therapy as applicable in humans as they are in mice. L.E.A.P.S. vaccines have promise for the treatment of rheumatoid arthritis and other inflammatory diseases and for infections, such as influenza and HSV1. The protective responses are characterized as Th1 immune and immunomodulatory responses with increased IL-12p70 and IFN-γ (Th1 cytokines) but reduced inflammatory cytokines TNF-α, IL-1 and IL-17 (Th2 and Th17 cytokines) and concomitant changes in antibody subtypes. LEAPS immunogens have been used directly in vivo or as ex vivo activators of DC which are then administered to the host.
authors: CEL-SCI Corporation Boone Blvd suite 802 Vienna, VA 22182, USA.
authors: Daniel H
authors: DH
authors: Zimmerman
authors: Harold
authors: H
authors: Steiner
authors: Roy
authors: R
authors: Carmabula
authors: Eyal
authors: E
authors: Talor
authors: Ken S
authors: KS
authors: Rosenthal
keywords: Antiviral vaccines; Cytokines; Dendritic cell; Immune response; Mode of action; Peptide; T cells; Vaccines; autoimmunity
references: Int Immunol. 2004 May;16(5):737-45
references: 15096482
references: Comp Med. 2005 Apr;55(2):114-22
references: 15884771
references: J Clin Invest. 2013 Jul;123(7):2850-61
references: 23934125
references: J Virol. 2002 May;76(9):4212-21
references: 11932386
references: Virol J. 2006 Dec 06;3:102
references: 17150104
references: Microb Biotechnol. 2012 Mar;5(2):203-13
references: 21895992
references: Vaccine. 2001 Sep 14;19(32):4750-9
references: 11535326
references: Immunity. 2003 Nov;19(5):641-4
references: 14614851
references: J Clin Invest. 2002 Oct;110(7):1021-7
references: 12370280
references: J Med Virol. 1985 Jul;16(3):283-7
references: 2993498
references: Vaccine. 2002 May 22;20(17-18):2358-68
references: 12009292
references: Hum Vaccin. 2011 Apr;7(4):402-9
references: 21471731
references: Postgrad Med. 2000 Mar;107(3):189-95, 199-200
references: 10728143
references: J Allergy Clin Immunol. 2004 Sep;114(3):607-13
references: 15356565
references: Vaccine. 2003 Oct 1;21(27-30):4410-20
references: 14505924
references: Vaccine. 2004 Jun 23;22(19):2368-73
references: 15193396
references: Nature. 1992 Apr 30;356(6372):799-801
references: 1574119
references: Pathophysiology. 2005 Oct;12(3):167-81
references: 16171986
references: Cancer Res. 1980 Dec;40(12):4640-7
references: 6254649
references: Vaccine. 2010 Aug 2;28(34):5533-42
references: 20600501
references: Science. 2009 Apr 10;324(5924):246-51
references: 19251591
references: J Med Virol. 1984;13(2):163-70
references: 6319589
references: BMC Immunol. 2003 Feb 22;4:2
references: 12597780
references: Eur J Immunol. 2007 Dec;37(12):3576-81
references: 18000952
references: Curr Top Microbiol Immunol. 1992;179:57-74
references: 1499350
references: Am J Pathol. 2008 May;172(5):1195-208
references: 18403598
references: Nat Struct Mol Biol. 2009 Mar;16(3):265-73
references: 19234466
references: J Med Virol. 1985 Mar;15(3):215-22
references: 2984324
references: J Immunol. 1999 May 15;162(10):6024-8
references: 10229842
references: J Virol. 2009 Mar;83(6):2553-62
references: 19109379
references: J Immunol. 1992 Aug 15;149(4):1439-43
references: 1380044
references: Circulation. 2005 Nov 29;112(22):3400-7
references: 16316965
references: Nature. 1992 Apr 30;356(6372):796-8
references: 1574118
references: Front Biosci. 2005 Jan 01;10:966-74
references: 15569635
references: J Virol. 2005 Jun;79(11):6644-54
references: 15890902
references: J Biol Chem. 1983 May 25;258(10):6179-86
references: 6189821
references: Vaccine. 1999 Feb 12;17(6):535-42
references: 10075159
references: Vaccine. 2007 Sep 28;25(39-40):6852-62
references: 17719149
references: J Exp Med. 1995 Nov 1;182(5):1291-300
references: 7595200
references: Mol Immunol. 2006 Jul;43(14):2195-206
references: 16472860
references: Vaccine. 1995 Dec;13(17):1706-12
references: 8719523
references: Vaccine. 2004 Aug 13;22(23-24):2993-3003
references: 15297047
references: Vaccine. 2003 Jun 2;21(19-20):2616-26
references: 12744898
references: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1867-72
references: 12576552
references: Immunity. 2000 Jan;12(1):83-93
references: 10661408
references: Methods Mol Med. 2004;102:195-212
references: 15286387
references: Int Immunopharmacol. 2010 Apr;10(4):412-21
references: 20074669
references: Curr Opin Microbiol. 1998 Aug;1(4):430-5
references: 10066506
references: J Virol. 1995 Dec;69(12):8178-9
references: 7494346
references: Int Immunopharmacol. 2008 May;8(5):624-33
references: 18387504
references: Blood. 2005 Aug 15;106(4):1305-13
references: 15845898
references: Vaccine. 2012 Jun 29;30(31):4655-60
references: 22575166
references: Arthritis Rheum. 2010 Aug;62(8):2192-205
references: 20506322
references: Int J Med Microbiol. 2010 Jan;300(1):19-24
references: 19781988
references: Cell Immunol. 2010;262(1):1-5
references: 20163792
references: Front Biosci. 2005 Jan 01;10:790-8
references: 15569618
references: Front Biosci. 2005 Jan 01;10:478-82
references: 15574384
references: J Virol. 2002 Nov;76(21):10717-23
references: 12368314
references: Arch Virol. 2002 Apr;147(4):763-73
references: 12038686